Home-Use LED Light Therapy Patents: Who Leads, Trends 2026
Home-Use LED Light Therapy Patents: Concentration at the Top, Room at the Edges
70.2% concentration. The top 5 of 57 ranked assignees hold 181 of 258 records in scope — a field where a handful of filers set the terms for everyone else. Filings ran from 20 in 2017 to a peak of 32 in 2018, cooled through the early 2020s, then rebounded — 7 filings in 2021 climbing to 13 in 2024, an 86% increase. The 2026 figure (2 so far) is a partial year and will rise as later publications land.
- 1JOHNSON & JOHNSON CONSUMER INC128
- 2ELLEX MEDICAL17
- 3LUMIPORT LLC15
- 4KENVUE BRANDS LLC12
- 5POWELL STEVEN D9
See the full home-use led light therapy analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Frequently asked questions
How concentrated is the home-use LED light therapy patent field?
It is highly concentrated. Of 57 ranked assignees covering 258 records in scope, the top 5 alone account for 181 records, or 70.2% of the total. The top 10 push that to 84.5%. That means most core claim territory around irradiance output, wavelength selection and treatment duration is already held by a small number of filers, and new entrants should expect dense prior art in that core space.
Is patent filing activity in this field growing or slowing down?
Filing activity is recovering after a mid-period dip. Volume peaked at 32 records in 2018, declined through the early 2020s, then rose from 7 filings in 2021 to 13 in 2024, an 86% increase over that span. The 2025 and 2026 figures in the dataset are still incomplete because publication typically lags filing by around 18 months, so the most recent years should not be read as a slowdown.
Which parts of home-use LED light therapy technology are least covered by existing patents?
The bulk of filing activity, 87.6% of the 258 records, sits in A61N electrotherapy and radiation-therapy claims. Adjacent classes such as G16H healthcare informatics (4.3%), A61H physical therapy and massage (1.9%), and A61L sterilising and disinfecting (1.6%) carry far fewer filings. That gap suggests treatment-protocol software, hygiene features and combination-therapy devices are comparatively open ground for new claims.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Home-Use LED Light Therapy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.